Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06214221 · ClinicalTrials.gov registry record · NA
Using Signos mHealth Platform in Adults for Weight Management
A NA study of Weight Loss and Overweight and Obesity, sponsored by Signos.
- Active
- Registry status
- NA
- Development phase
- 380
- Enrollment target
- 5
- Study locations
NCT06214221 is a NA study of Weight Loss and Overweight and Obesity that is active but no longer recruiting, run by Signos. The registered enrollment target is 380 participants, below the 1,498-participant average among 116 other Weight Loss trials with a reported enrollment target (75% lower). The trial reports 5 study locations across 5 states.
The verdict
NCT06214221, a NA study of Weight Loss and Overweight and Obesity, is active but no longer recruiting, sponsored by Signos.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 380 participants
- Enrollment target
- 5
- Study locations
Study Summary
Metabolic syndrome and resulting downstream health effects remains a growing health concern. In published trials, the use of continuous glucose monitoring (CGM) assists behavioral changes efforts, leading to improved adherence and results from diet and exercise changes in individuals with obesity. Mobile health (mHealth) platforms provide satisfactory, easy-to-use tools that help participants in the pursuit of weight change goals. The investigators hypothesize that the use of CGM data and targeted coaching and nutrition education will assist with weight optimization goals in the general (non-diabetic) population using the Signos mHealth platform, with associated health benefits.
Conditions Studied
Interventions
- DEVICE Signos System
- OTHER Standard Lifestyle Education
Study Locations (5)
Arizona
- Helios Clinical Research (Phoenix) - Phoenix
California
- Diablo Clinical Research - Walnut Creek
Florida
- Segal Trials - North Miami
Texas
- Helios Clinical Research - Houston
Washington
- Seattle Clinical Research - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 380 participants |
| Start Date | 2024-01-02 |
| Est. Completion | 2026-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06214221
The ClinicalTrials.gov registry entry for NCT06214221 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 380 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,498-participant average among 116 other Weight Loss trials with a reported enrollment target (75% lower). The listed sponsor is Signos, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Weight Loss appearing as the primary indexed condition, and to 2 interventions - of which Signos System is the first listed.
NCT06214221 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Arizona, California, Florida.
Frequently Asked Questions
What is clinical trial NCT06214221 about?
NCT06214221 is a clinical study titled "Using Signos mHealth Platform in Adults for Weight Management". Metabolic syndrome and resulting downstream health effects remains a growing health concern. In published trials, the use of continuous glucose monitoring (CGM) assists behavioral changes efforts, leading to improved adherence and results from diet and exercise changes in individuals with obesity. M...
What is the current status of trial NCT06214221?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 380 participants. The study started on 2024-01-02. Estimated completion is 2026-04-30.
What conditions does trial NCT06214221 study?
This clinical trial studies the following conditions: Weight Loss, Overweight and Obesity, Metabolic Syndrome.
What interventions are being tested in trial NCT06214221?
The interventions under investigation include: Signos System (DEVICE), Standard Lifestyle Education (OTHER).
Who is sponsoring clinical trial NCT06214221?
This trial is sponsored by Signos, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06214221 being conducted?
This trial has 5 study locations across Arizona, California, Florida, Texas, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Weight Loss
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Metabolic Health, Bones and Nuts During Weight Loss in Adults
RECRUITING · NA
-
FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)
RECRUITING · NA
-
Exercise Effects on Adipose Tissue Structure and Function
RECRUITING · NA
-
Circadian Time Restricted Eating
RECRUITING · NA
-
Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.